Although they have demonstrated that WNT5a increased inflammation and oxidative stress via PI3K/Akt/NF‐κB signalling in human GCs, they did not confirm that WNT5a activated PI3K/Akt/NF‐κB signalling in GCs of PCOS patients. This evidence concerns the gene NFKB1 and polycystic ovary syndrome.